Neutralization heterogeneity of United Kingdom and South-African SARS-CoV-2 variants in BNT162b2-vaccinated or convalescent COVID-19 healthcare workers

There are concerns about neutralizing antibodies (NAbs) potency against SARS-CoV-2 variants. Despite decreased NAb titers elicited by BNT162b2-vaccine against VOC202012/01 and 501Y.V2 strains, 28/29 healthcare workers (HCW) had a NAb titer ≥1:10. In contrast, six months after COVID-19 mild-forms, on...

Description complète

Enregistré dans:
Détails bibliographiques
Publié dans:Clin Infect Dis
Auteurs principaux: Marot, Stéphane, Malet, Isabelle, Leducq, Valentin, Abdi, Basma, Teyssou, Elisa, Soulie, Cathia, Wirden, Marc, Rodriguez, Christophe, Fourati, Slim, Pawlotsky, Jean-Michel, Boutolleau, David, Burrel, Sonia, Calvez, Vincent, Marcelin, Anne-Geneviève, Jary, Aude
Format: Artigo
Langue:Inglês
Publié: Oxford University Press 2021
Sujets:
Brief Report
Accès en ligne:https://ncbi.nlm.nih.gov/pmc/articles/PMC8244299/
https://ncbi.nlm.nih.gov/pubmed/34050731
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/cid/ciab492
Tags: Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!

Documents similaires